Humana Financials - Benzinga

Humana Inc

HUMNYSE

Trade with Public

Trade with Public

$400.40

-6.12-1.51%

마지막 업데이트: Sep 4, 3:31 PM

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 배당금 비교 옵션 주식 보고서

Humana Financials

Humana (HUM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Humana Reiterates FY26 Adjusted EPS Outlook Of At Least $9

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000049071/000004907126000052/hum-20260901.htm

Benzinga Newsdesk

CVRx Stock Is Falling Overnight: Here's What's Driving the Move

CVRx stock sinks after hours after lowering full-year revenue outlook despite revenue growth.

Tanya Rawat

US Insurer Humana Is Exiting More Medicare Advantage Plans in 2027— Here's Who Could Be Affected

Humana plans more Medicare Advantage plan exits in 2027 as it targets a 3% margin and reshapes its portfolio.

Tanya Rawat

Humana's Strong Quarter Fails To Impress

HUM stock drops premarket: Humana beats Q2 estimates, but fails to impress as industry peers raise expectations.

Vandana Singh

PRO
Update: Humana Q2 Adj. EPS $7.61 Beats $7.22 Estimate, Sales $40.888B Beat $40.611B Estimate

Benzinga Newsdesk

Humana FY2026 GAAP EPS expected to be more than $6.52 vs $8.55 Est

Humana (NYSE:HUM) FY2026 expected to be more than $6.52 vs $8.55 Est..

Benzinga News-desk

© 2026 Benzinga | All Rights Reserved